Business

Granules India gets USFDA nod for sleep aid drug

Drug firm Granules India on Friday said it has received the US health regulator's approval for Naproxen Sodium and Diphenhydramine Hydrochloride tablets, used for relief in occasional sleeplessness associated with minor aches and pains. The approved product is the generic equivalent of Aleve PM tablets of Bayer HealthCare LLC.

migrator

New Delhi

The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) for Naproxen Sodium and Diphenhydramine Hydrochloride tablets, 220 mg/25 mg (OTC), Granules said in a BSE filing. Granules now has a total of 31 ANDA approvals from the USFDA (29 Final approvals and 2 tentative approvals).

Shares of Granules India were trading 3.33 per cent higher at Rs 372.60 apiece on BSE.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Also Read

Power goes off at TVK EB Minister's event; he claims generator glitch, TNPDCL admits feeder fault

Tasmac gears up for fresh bar tenders in October, ‘spies’ on potential saboteurs

In lottery-less TN, fortune hunters wait for Keralam’s Rs 30 crore Onam bumper results on Sept 26

CM Vijay to visit Meenakshi Amman Temple on September 28 after launching TNTM scheme in Madurai

OpenAI says its models engaged with US government websites in new model misbehaviour disclosure

SCROLL FOR NEXT